N-[4-(4-Amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]-methylesulfonamide
CAS: 532959-63-0
Ref. 3D-NA162905
1mg | 232,00 € | ||
5mg | 517,00 € | ||
10mg | 647,00 € | ||
25mg | 814,00 € | ||
50mg | 1.044,00 € |
Informação sobre produto
N-{4-[4-amino-2-(ethyl)-1H-imidazo[4,5-c]quinolin-1-yl]butyl}methylesulfonamide (AEMI) is a novel immunomodulator that has been shown to have anticarcinogenic effects in preclinical studies. It induces an immune response in patients with cancer by stimulating the production of interleukin 1 receptor antagonist and other cytokines. AEMI also activates toll-like receptor 2, which is involved in the innate immunity pathway and triggers an orchestrated immune response to destroy tumour cells. The clinical response to AEMI is dose proportional and shows no adverse effects on healthy cells or tissues.
Propriedades químicas
Consulta técnica sobre: 3D-NA162905 N-[4-(4-Amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]-methylesulfonamide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.